Market Place
Sourcing Support
FDA steps in to address challenges faced by cell and gene therapies
The year 2023 was a rather
tough one for cell and gene therapy (CGT) companies. There was news abou
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
